Cleveland Clinic 29th Annual Diabetes Therapeutics, Technology and Surgery

Cleveland Clinic 29th Annual Diabetes Therapeutics, Technology and Surgery

Endocrinology

Overview

The 29th Annual Diabetes Day: Therapeutics, Technology and Surgery is presented by the Cleveland Clinic Department of Endocrinology, Diabetes and Metabolism to provide up-to-date reviews of management strategies and research on the complications of diabetes. Key topic areas that will be addressed include:Review of therapeutic options to manage both Type 1 and 2 diabetes and their complications, including a pump update, and new insulins and continuous glucose monitoring updates.

Importance of maintaining muscle mass during obesity management. Latest technology in insulin pumps New roles for GLP1 receptor agonists SGLT-2 inhibitors and mineralocorticoid receptor antagonists Complications of GLP-1 receptor agonists This year’s curriculum will also feature discussions about:Glucose variability and diabetes Effects of high fat and high protein diets on glucose control Effects of GLP-1 on sleep apnea Nutritional supplements in treatment of DM2The goal of this symposium is to increase practitioners’ competence and clinical performance in treating diabetes and its complications and, ultimately, to improve patient outcomes.

Course Details

• Price: $45.00
• Access Type: Lifetime
• Delivery Method: Google Drive Link, Offline
• Content Format: Mixed

What's Included

• Video lectures and recordings

Target Audience

• Residents
• Fellows
• Physician
• Nurses
• NP

Key Features

• Expert-led instruction and content
• Comprehensive coverage of topic area
• Flexible learning schedule
• Lifetime access to all materials